
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| child | TDLo | intravenous | 18750mg/kg/5D (18750mg/kg) | BRAIN AND COVERINGS: ENCEPHALITIS SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE |
Cancer Treatment Reports. Vol. 70, Pg. 1225, 1986. |
| man | TDLo | intravenous | 11655mg/kg/5D (11655mg/kg) | SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) |
Cancer Treatment Reports. Vol. 70, Pg. 1449, 1986. |
| man | TDLo | intravenous | 17760mg/kg/5D (17760mg/kg) | BRAIN AND COVERINGS: DEMYELINATION BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" BEHAVIORAL: COMA |
Cancer Treatment Reports. Vol. 70, Pg. 1225, 1986. |
| mouse | LD50 | intravenous | 1236mg/kg (1236mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | National Technical Information Service. Vol. PB83-195685, |
| women | LDLo | intravenous | 14245mg/kg/5D (14245mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE BEHAVIORAL: EXCITEMENT SKIN AND APPENDAGES (SKIN): SWEATING: OTHER |
Cancer Treatment Reports. Vol. 70, Pg. 1449, 1986. |
| women | TDLo | intravenous | 23125mg/kg/5D (23125mg/kg) | BRAIN AND COVERINGS: ENCEPHALITIS SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) |
Cancer Treatment Reports. Vol. 70, Pg. 1225, 1986 |